Pioneering diagnostics

Molecular Diagnostics 

bioMérieux is joining forces with specialists in molecular diagnostics to develop new solutions for clinical and industrial applications.

Molecular biology brings a very sophisticated level of sensitivity and specificity to diagnostics. Our molecular biology-based solutions are developed for applications in both clinical diagnostics and industrial microbiological control.


  • bioMérieux acquired ARGENE, a company specialized in molecular diagnostics, in 2011. This has expanded our infectious disease offering with, in particular, tests used for monitoring immunocompromised patients.
  • bioMérieux finalizes acquisition of the U.S. company BioFire, specialized in molecular biology. With this acquisition, bioMérieux consolidates its position as a major player in infectious disease diagnostics and strengthens its presence in the United States. Find out more…